Adjudicación del Contrato Específico del Medicamento USTEKINUMAB, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el CONSORCI SANITARI INTEGRAL
TED · 476431-2026Award noticeawardedNo deadline given
Value
Estimated€528,490 · 528,489.5 EUR
Awarded€528,490 · 528,489.5 EUR
WinnerBIOCON BIOLOGICS SPAIN
Who already wins at this buyer
Firms with recorded awards from Consorci Sanitari Integral in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Laboratorios LEO Pharma, S.A. | 2 | €787,247 | 2026-05-07 |
| UCB PHARMA, S.A. | 1 | €1,887,515 | 2026-06-05 |
| Abast Medica S.L. | 1 | €409,179 | 2026-06-30 |
| ASTRAZENECA FARMACEUTICA SPAIN, S.A. | 1 | €353,274 | 2026-05-05 |
| GETINGE GROUP SPAIN, S.L.U. | 1 | €268,000 | 2026-06-26 |
Full buyer profile: what Consorci Sanitari Integral buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Adjudicación del Contrato Específico del Medicamento USTEKINUMAB para el CONSORCI SANITARI INTEGRAL, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, tramitado por el Consorci de Salut i d’Atenció Social de Catalunya
Similar tenders
Closest by meaning — across languages, via embeddings.